This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Notes
* Nature Biotechnology does not guarantee the veracity, reliability, or completeness of any information provided on this page; it is not responsible for any errors or omissions or for any results obtained from the use of such information; it will not be liable for any loss, damage, or investment decision arising from a reader's reliance on the information provided.
Additional information
Tom Jacobs, of the Internet site Motley Fool (), provides his angle on biotechnology investments. Read on and become “Foolishly” informed * . He can be contacted about biotechnology and investing at . Jacobs cannot give individual investment advice but welcomes any.
Rights and permissions
About this article
Cite this article
Jacobs, T. Going short on biotech. Nat Biotechnol 21, 1133 (2003). https://doi.org/10.1038/nbt1003-1133
Issue date:
DOI: https://doi.org/10.1038/nbt1003-1133
This article is cited by
-
News In Brief
Nature Biotechnology (2004)